Market Cap 7.76B
Revenue (ttm) 2.35B
Net Income (ttm) 128.37M
EPS (ttm) N/A
PE Ratio 295.58
Forward PE 675.62
Profit Margin 5.47%
Debt to Equity Ratio 0.00
Volume 12,550,440
Avg Vol 26,816,639
Day's Range N/A - N/A
Shares Out 231.46M
Stochastic %K 68%
Beta 2.37
Analysts Sell
Price Target $28.54

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 415 851 0195
Address:
2269 Chestnut Street, Suite 523, San Francisco, United States
inquisitive1
inquisitive1 Jun. 24 at 1:44 AM
$HIMS I don't think it's the end of the world for HIMS, if we trade between $33 and $36 over the next two weeks, before another leg up.
0 · Reply
MorganChase
MorganChase Jun. 24 at 1:36 AM
$HIMS 🤯🤯🤯💵💵💵💵💵
0 · Reply
CapitalTitan
CapitalTitan Jun. 24 at 1:29 AM
$HIMS $ESTC $ADBE $BB is trading in a way that reflects AI momentum continuation. I am staying disciplined and letting the chart confirm the narrative.
0 · Reply
Bigg554
Bigg554 Jun. 24 at 12:59 AM
$HIMS I’ve used the Wolverine peptide blend. It works. I invested in this because peptides are the future of preventative medicine. Stanford’s Andrew Huenermann already called them out! The meeting is in a month. I imagine the price action leading up is going to be epic. If it’s sell the news when they decide that means the next few weeks will see a massive run up in price. Regardless I’m in for the long haul tint this next month is going to be fun to watch!
0 · Reply
IdioSyncro
IdioSyncro Jun. 24 at 12:43 AM
$HIMS did hims open up their peptide factory yet? Will it be 2030 when they get FDA approval?
0 · Reply
Panopticon2024
Panopticon2024 Jun. 24 at 12:37 AM
$QS 22.4M volume. That is huge. Compare to $HIMS $PL $SOFI other popular retail squeeze names. This is ready to explode.
0 · Reply
Rooksteady
Rooksteady Jun. 24 at 12:07 AM
$APLD followed @professorpump over here...going to try and show him how to make some money off this pipe dream...still a. $HIMS hater though...we watching to see if there's one more pump out there before bleeding into surprise crappy earnings..
1 · Reply
AIInvestorr
AIInvestorr Jun. 23 at 11:41 PM
My position in $DKNG $HIMS $ADBE is based on liquidity rotation setup. Volatility is expected, but the structure still looks intact.
0 · Reply
AXLFI_HQ
AXLFI_HQ Jun. 23 at 11:25 PM
$HIMS Telehealth platforms are capturing accelerating growth in weight-loss and peptide therapeutics, with FDA regulatory decisions creating binary outcomes for market sizing and competitive positioning. Learn more: https://axlfi.com/themes/380
0 · Reply
BullNavigatorr
BullNavigatorr Jun. 23 at 10:36 PM
My position in $HIMS $GLXY is based on macro sentiment shift. Volatility is expected, but the structure still looks intact.
0 · Reply
Latest News on HIMS
Hims & Hers Health Transcript: AGM 2026

Jun 11, 2026, 2:00 PM EDT - 12 days ago

Hims & Hers Health Transcript: AGM 2026


Hims & Hers Health Slides: Investor presentation

May 28, 2026, 7:00 AM EDT - 26 days ago

Hims & Hers Health Slides: Investor presentation


Here’s Why Hims & Hers Stock Tumbled 9% Today, 5/18/26

2026-05-18T15:29:13.000Z - 5 weeks ago

Here’s Why Hims & Hers Stock Tumbled 9% Today, 5/18/26

NVO


Hims & Hers Drops After Earnings Miss & HIMS Options Trade

May 12, 2026, 11:30 AM EDT - 6 weeks ago

Hims & Hers Drops After Earnings Miss & HIMS Options Trade


Hims & Hers Health Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

Hims & Hers Health Earnings Call Transcript: Q1 2026


Hims & Hers Health Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

Hims & Hers Health Slides: Q1 2026


Hims & Hers Health Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

Hims & Hers Health Earnings release: Q1 2026


Hims & Hers Health Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

Hims & Hers Health Quarterly report: Q1 2026


Hims & Hers Health Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Hims & Hers Health Proxy statement: Proxy filing


Hims & Hers Health Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Hims & Hers Health Proxy statement: Proxy filing


Hims & Hers surges 4% as peptide policy shift unlocks growth

Apr 16, 2026, 10:42 AM EDT - 2 months ago

Hims & Hers surges 4% as peptide policy shift unlocks growth


Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers

Mar 26, 2026, 12:00 PM EDT - 3 months ago

Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers


Hims & Hers Names Kathryn Beiser as Chief Communications Officer

Mar 10, 2026, 8:08 PM EDT - 3 months ago

Hims & Hers Names Kathryn Beiser as Chief Communications Officer


HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

Mar 9, 2026, 11:00 AM EDT - 3 months ago

HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

NVO


Novo Nordisk drops Him & Hers lawsuit

Mar 9, 2026, 10:38 AM EDT - 3 months ago

Novo Nordisk drops Him & Hers lawsuit

NVO


Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal

Mar 9, 2026, 9:23 AM EDT - 3 months ago

Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal


What's Happening With HIMS Stock?

Mar 9, 2026, 8:35 AM EDT - 3 months ago

What's Happening With HIMS Stock?


inquisitive1
inquisitive1 Jun. 24 at 1:44 AM
$HIMS I don't think it's the end of the world for HIMS, if we trade between $33 and $36 over the next two weeks, before another leg up.
0 · Reply
MorganChase
MorganChase Jun. 24 at 1:36 AM
$HIMS 🤯🤯🤯💵💵💵💵💵
0 · Reply
CapitalTitan
CapitalTitan Jun. 24 at 1:29 AM
$HIMS $ESTC $ADBE $BB is trading in a way that reflects AI momentum continuation. I am staying disciplined and letting the chart confirm the narrative.
0 · Reply
Bigg554
Bigg554 Jun. 24 at 12:59 AM
$HIMS I’ve used the Wolverine peptide blend. It works. I invested in this because peptides are the future of preventative medicine. Stanford’s Andrew Huenermann already called them out! The meeting is in a month. I imagine the price action leading up is going to be epic. If it’s sell the news when they decide that means the next few weeks will see a massive run up in price. Regardless I’m in for the long haul tint this next month is going to be fun to watch!
0 · Reply
IdioSyncro
IdioSyncro Jun. 24 at 12:43 AM
$HIMS did hims open up their peptide factory yet? Will it be 2030 when they get FDA approval?
0 · Reply
Panopticon2024
Panopticon2024 Jun. 24 at 12:37 AM
$QS 22.4M volume. That is huge. Compare to $HIMS $PL $SOFI other popular retail squeeze names. This is ready to explode.
0 · Reply
Rooksteady
Rooksteady Jun. 24 at 12:07 AM
$APLD followed @professorpump over here...going to try and show him how to make some money off this pipe dream...still a. $HIMS hater though...we watching to see if there's one more pump out there before bleeding into surprise crappy earnings..
1 · Reply
AIInvestorr
AIInvestorr Jun. 23 at 11:41 PM
My position in $DKNG $HIMS $ADBE is based on liquidity rotation setup. Volatility is expected, but the structure still looks intact.
0 · Reply
AXLFI_HQ
AXLFI_HQ Jun. 23 at 11:25 PM
$HIMS Telehealth platforms are capturing accelerating growth in weight-loss and peptide therapeutics, with FDA regulatory decisions creating binary outcomes for market sizing and competitive positioning. Learn more: https://axlfi.com/themes/380
0 · Reply
BullNavigatorr
BullNavigatorr Jun. 23 at 10:36 PM
My position in $HIMS $GLXY is based on macro sentiment shift. Volatility is expected, but the structure still looks intact.
0 · Reply
isEEu28
isEEu28 Jun. 23 at 10:29 PM
0 · Reply
Tokenaxis
Tokenaxis Jun. 23 at 9:52 PM
$HIMS Closed 2 HIMS 33P 06/26 @ $1.15 (Entry: $1.11) | Gain: +3.6% Solid session today. 📈 Profits were taken, risk was managed, and tomorrow’s game plan is already prepared. Now we wait for the market to come to us. 🚀
1 · Reply
SigmaLab
SigmaLab Jun. 23 at 9:20 PM
$HIMS CMO Carrol Harrison sold about $830.4K worth of shares. Worth pointing out: this was a pre-planned sale from last year, so it’s not really a “surprise” type of print. I’ve seen these get overread a lot scheduled insider selling usually has more to do with personal liquidity, taxes, or compensation timing than anything about the actual business outlook. Doesn’t really change the setup on its own, even if it grabs attention in the tape. Feels more like routine insider flow than a signal.
0 · Reply
JACOHE91595
JACOHE91595 Jun. 23 at 9:16 PM
$HIMS I have a hunch big money will start rotating out of AI and Semi’s temporarily given the volatility and perception of a bubble. We should stand to gain nicely from that given our story. It’s just gone unnoticed till relatively recently. All in due time. I have a majority of my portfolio parked here for a while
0 · Reply
PikaBullRun
PikaBullRun Jun. 23 at 8:57 PM
$HIMS average analyst price target is up to $29. Just 3 months ago it was near $15 with bankruptcy chatter. Up 44% from a $22 entry node. Reratings are just getting started. Standing firm against the crowd. Long-term conviction.
0 · Reply
NasdaqVision
NasdaqVision Jun. 23 at 8:35 PM
Still holding $RUM $HIMS $XNDU $UCO. The market is pricing in macro sentiment shift, but I think the longer-term story is still developing.
0 · Reply
Ethanalphatrades
Ethanalphatrades Jun. 23 at 8:22 PM
$HIMS Sell-side targets have moved higher, with the average analyst PT now around $29. Just a few months ago, sentiment was significantly more negative, with the stock trading near $15 and widely viewed as structurally challenged. Price action has since reflected a meaningful re-rating, with continued volatility as expectations adjust. At current levels, the key question is whether growth can sustain enough consistency to justify further multiple expansion from here.
0 · Reply
stockwarrior86
stockwarrior86 Jun. 23 at 7:57 PM
$HIMS down 2.50$ in two days isnt tragic here. This may continue down tomorrow so stand fast bulls. July is our month and it’s right around the corner
0 · Reply
stockwarrior86
stockwarrior86 Jun. 23 at 7:46 PM
$HIMS this will be in the 40s this July
0 · Reply
CrazyJuice
CrazyJuice Jun. 23 at 7:43 PM
$HIMS unbreakable today, even with 1.5 hours of continuous selling. Any catalyst and this runs like crazy
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jun. 23 at 7:25 PM
Category breakdown - positioning winners based on current momentum and relative strength across sectors. No hype, just tape-driven leadership signals. Satellite connectivity: $ASTS over $SPCX - stronger infrastructure ramp and clearer commercial scaling path Drone Defense: $AVAV over $ONDS - more established defense platform and consistent demand tailwinds Health: $HIMS over OSCR - faster growth trajectory and stronger retail expansion narrative In volatile tapes, capital doesn’t spread evenly - it concentrates in the leaders. Stay aligned with strength, not lagging names. Are you going to miss out again?
0 · Reply
Yourearegard
Yourearegard Jun. 23 at 7:15 PM
$HIMS keep shorting it as the institutions cover 😂
1 · Reply